Versor Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,927
| Closed | -$1.09M | – | 745 |
|
|
2024
Q4 | $1.09M | Buy |
+5,927
| New | +$1.09M | 0.19% | 134 |
|
|
2024
Q3 | – | Sell |
-5,740
| Closed | -$1.19M | – | 794 |
|
|
2024
Q2 | $1.19M | Buy |
+5,740
| New | +$1.19M | 0.22% | 113 |
|
|
2024
Q1 | – | Sell |
-3,088
| Closed | -$730K | – | 716 |
|
|
2023
Q4 | $730K | Sell |
3,088
-1,202
| -28% | -$284K | 0.15% | 215 |
|
|
2023
Q3 | $841K | Buy |
+4,290
| New | +$841K | 0.17% | 152 |
|
|
2023
Q1 | – | Sell |
-4,457
| Closed | -$971K | – | 735 |
|
|
2022
Q4 | $971K | Buy |
4,457
+3,257
| +271% | +$710K | 0.08% | 154 |
|
|
2022
Q3 | $236K | Sell |
1,200
-6,084
| -84% | -$1.2M | 0.01% | 683 |
|
|
2022
Q2 | $1.56M | Buy |
+7,284
| New | +$1.56M | 0.06% | 135 |
|